Pyrazolo [3 , 4-d] azepine derivatives as histamine H3 antagonists

Details for Australian Patent Application No. 2006286897 (hide)

Owner Glaxo Group Limited

Inventors Bamford, Mark James; Wilson, David Matthew

Agent Davies Collison Cave

Pub. Number AU-A-2006286897

PCT Pub. Number WO2007/025596

Priority 0513886.2 06.07.05 GB

Filing date 4 July 2006

Wipo publication date 8 March 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/025596 Priority application(s): WO2007/025596

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006286906-An imaging device for single x-ray photon counting

2006286896-Use of soluble guanylate cyclase activators for treating reperfusion damage